Form 8-K - Current report:
SEC Accession No. 0001437749-24-036247
Filing Date
2024-11-26
Accepted
2024-11-26 14:00:34
Documents
19
Period of Report
2024-11-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dyai20241120_8k.htm   iXBRL 8-K 29804
2 EXHIBIT 10.1 ex_751025.htm EX-10.1 53412
3 EXHIBIT 99.1 ex_750590.htm EX-99.1 11135
8 ex_750590img001.jpg GRAPHIC 2561
9 ex_751025img001.jpg GRAPHIC 4263
10 ex_751025img002.jpg GRAPHIC 2875
  Complete submission text file 0001437749-24-036247.txt   252630

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA dyai-20241121.xsd EX-101.SCH 3410
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dyai-20241121_def.xml EX-101.DEF 11425
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE dyai-20241121_lab.xml EX-101.LAB 15311
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dyai-20241121_pre.xml EX-101.PRE 11585
22 EXTRACTED XBRL INSTANCE DOCUMENT dyai20241120_8k_htm.xml XML 2845
Mailing Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477
Business Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Filer) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32513 | Film No.: 241501620
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)